drugset
drugset / Trial / NCT01258777

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

NCT01258777 ↗

Phase 1 Completed 49 enrolled Centocor, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetics of golimumab in Japanese and Caucasian Males.

Timeline

Start
2010-10
Primary completion
—
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Golimumab Monoclonal antibody 200 mg Subcutaneous
Subject Golimumab Monoclonal antibody 400 mg Subcutaneous

Indications

No indication recorded.